<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">docru</journal-id><journal-title-group><journal-title xml:lang="ru">Доктор.Ру</journal-title><trans-title-group xml:lang="en"><trans-title>Title</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1727-2378</issn><issn pub-type="epub">2713-2994</issn><publisher><publisher-name>ООО "ГК "РУСМЕДИКАЛ"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31550/1727-2378-2022-21-2-51-55</article-id><article-id custom-type="elpub" pub-id-type="custom">docru-70</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТЕРАПИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INTERNAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Прогностические модели риска развития интрадиализной гипертензии: роль параметров артериальной ригидности</article-title><trans-title-group xml:lang="en"><trans-title>Prediction Models of Intradialytic Hypertension: The Role of Arterial Stiffness Parameters</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0640-6848</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Токарева</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Tokareva</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Токарева Анастасия Сергеевна  — ассистент кафедры госпитальной терапии и общей врачебной практики имени В.Г. Вогралика</p><p>603005, г. Нижний Новгород</p></bio><email xlink:type="simple">toktokareva@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7581-4138</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Боровкова</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Borovkova</surname><given-names>N. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Боровкова Наталья Юрьевна — д. м. н., доцент, профессор кафедры госпитальной терапии и общей врачебной практики имени В.Г. Вогралика</p><p>603005, г. Нижний Новгород</p></bio><email xlink:type="simple">borovkov-nn@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2900-5986</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Линёва</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Lineva</surname><given-names>N. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Линёва Наталья Юрьевна — заведующая отделением диализа и гравитационной хирургии крови 603093, г. Нижний Новгород</p></bio><email xlink:type="simple">lineva_natalja@rambler.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4649-2437</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полякова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Polyakova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полякова Ирина Владимировна — к. м. н., ассистент кафедры госпитальной терапии и общей врачебной практики имени В.Г. Вогралика</p><p>60300, г. Нижний Новгород</p></bio><email xlink:type="simple">poliakova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Приволжский исследовательский медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ НО «Нижегородская областная клиническая больница им. Н.А. Семашко»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.A. Semashko Nizhny Novgorod Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>15</day><month>02</month><year>2025</year></pub-date><volume>21</volume><issue>2</issue><issue-title>ТЕРАПИЯ</issue-title><fpage>51</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Токарева А.С., Боровкова Н.Ю., Линёва Н.Ю., Полякова И.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Токарева А.С., Боровкова Н.Ю., Линёва Н.Ю., Полякова И.В.</copyright-holder><copyright-holder xml:lang="en">Tokareva A.S., Borovkova N.Y., Lineva N.Y., Polyakova I.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://docru.elpub.ru/jour/article/view/70">https://docru.elpub.ru/jour/article/view/70</self-uri><abstract><p>Цель исследования — уточнить прогностическое значение параметров артериальной ригидности в развитии интрадиализной гипертензии (ИДГ) у пациентов на программном гемодиализе (ГД).</p><sec><title>Дизайн</title><p>Дизайн: проспективное исследование.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование включены 45 пациентов на программном ГД. В качестве критерия ИДГ использовалось повышение систолического артериального давления (АД) &gt; 10 мм рт. ст. после процедуры ГД более чем в 4 из 6 сеансов в период, предшествовавший проведению суточного мониторирования АД (СМАД). Показатели артериальной ригидности оценивали с помощью прибора СМАД. Фиксировали демографические данные пациентов и данные объективного обследования, лабораторные показатели, стаж ГД, сопутствующие сердечно-сосудистые заболевания, проводимую лекарственную терапию.</p></sec><sec><title>Результаты</title><p>Результаты. Средний возраст пациентов составил 51 [41; 61] год, стаж ГД — 4,5 [1,1; 7,8] года. ИДГ имела место у 20 пациентов и, по данным многофакторного корреляционного анализа, была ассоциирована с возрастом пациента (относительный риск (ОР) = 3,78; 95%-ный доверительный интервал (ДИ): 1,29–11,04) и индексом аугментации (augmentation index, AIx) (ОР = 7,75; 95%-ный ДИ: 2,65–22,7). Обратная корреляция наблюдалась между развитием ИДГ и временем распространения отраженной волны (reflection wave transmission time, RWTT100–60 ) (ОР = 0,27; 95%-ный ДИ: 0,14–0,53), наличием диабетической нефропатии (ОР = 0,34; 95%-ный ДИ: 0,094–1,251), оста  точным диурезом (ОР = 0,43; 95%-ный ДИ: 0,21–0,87) и уровнем альбумина (ОР = 0,12; 95%-ный ДИ: 0,02–0,79). При этом включение в математическую модель параметров артериальной ригидности повышало ее предиктивную способность с AUC = 0,886 до AUC = 0,978.</p></sec><sec><title>Заключение</title><p>Заключение. В настоящем исследовании показателей артериальной ригидности AIx ≥ –6,5% и RWTT 100–60 ≤ 134,5 м/с были ассоциированы с большей частотой ИДГ, что может свидетельствовать о ведущей роли прогрессирующей артериальной ригидности в развитии интрадиализных сердечно-сосудистых осложнений.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Study Objective</title><p>Study Objective: To define the predictive value of arterial stiffness parameters in the development of intradialytic hypertension (IDH) in patients undergoing long-term HD.</p></sec><sec><title>Study Design</title><p>Study Design: Prospective study.</p></sec><sec><title>Material and Methods</title><p>Material and Methods. The prospective study included 45 patients undergoing long-term HD. An IDH criterion was an increase in systolic blood pressure &gt;10 mm Hg after the HD in more than 4 out of 6 sessions during the period preceding 24-hour blood pressure monitoring (24BPM). Arterial stiffness parameters were assessed using a Vasotens-24 BPLab software package (by Peter Telegin, Russia). We recorded the demographics of patients and physical examination results, lab test results, duration of HD, concomitant cardiovascular diseases, and medications taken. For data analysis we used Statistics 26 application package (IBM SPSS).</p></sec><sec><title>Study Results</title><p>Study Results. The mean age of patients was 51 [41; 61] years old; HD duration was 4.5 [1.1; 7.8] years. IDH was recorded in 20 patients; the multivariate correlation analysis showed that IDH was associated with the patients’ age (HR = 3.78; 95% CI 1.29–11.04), with the augmentation index AIx (HR = 7.75; 95% CI 2.65–22.7). Inverse correlation was observed between IDH development and reflection wave   transmission time — RWTT 100–60 (HR = 0.27; 95% CI 0.14–0.53), presence of diabetic nephropathy (HR = 0.34; 95% CI 0.094–1.251), residual diuresis (HR = 0.43; 95% CI 0.21–0.87), and albumin level (HR = 0.12; 95% CI 0.02–0.79). Inclusion of arterial stiffness parameters into the mathematical model increased its predictive ability from AUC = 0.886 to AUC = 0.978.</p></sec><sec><title>Conclusion</title><p>Conclusion. In this study, AIx ≥ –6.5% and RWTT 100–60 ≤ 134.5 m/s were associated with a higher frequency of IDH, which can be a sign of the leading role of progressive artery stiffness in the development of intradialytic cardiovascular complications.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гемодиализ</kwd><kwd>интрадиализная гипертензия</kwd><kwd>артериальная ригидность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hemodialysis</kwd><kwd>intradialytic hypertension</kwd><kwd>arterial stiffness</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Van Buren P.N., Inrig J.K. Special situations: intradialytic hypertension/chronic hypertension and intradialytic hypotension. Semin. Dial. 2017; 30(6): 545–52. DOI: 10.1111/sdi.12631</mixed-citation><mixed-citation xml:lang="en">Van Buren P.N., Inrig J.K. Special situations: intradialytic hypertension/chronic hypertension and intradialytic hypotension. Semin. Dial. 2017; 30(6): 545–52. DOI: 10.1111/sdi.12631</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Van Buren P.N., Kim C., Toto R.D. et al. The prevalence of persistent intradialytic hypertension in a hemodialysis population with extended follow-up. Int. J. Artif. Organs. 2012; 35(12): 1031–8. DOI: 10.5301/ijao.5000126</mixed-citation><mixed-citation xml:lang="en">Van Buren P.N., Kim C., Toto R.D. et al. The prevalence of persistent intradialytic hypertension in a hemodialysis population with extended follow-up. Int. J. Artif. Organs. 2012; 35(12): 1031–8. DOI: 10.5301/ijao.5000126</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Assimon M.M., Flythe J.E. Intradialytic blood pressure abnormalities: the highs, the lows and all that lies between. Am. J. Nephrol. 2015; 42(5): 337–50. DOI: 10.1159/000441982</mixed-citation><mixed-citation xml:lang="en">Assimon M.M., Flythe J.E. Intradialytic blood pressure abnormalities: the highs, the lows and all that lies between. Am. J. Nephrol. 2015; 42(5): 337–50. DOI: 10.1159/000441982</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Shamir A.R., Karembelkar A., Yabes J. et al. Association of intradialytic hypertension with left ventricular mass in hypertensive hemodialysis patients enrolled in the Blood Pressure in Dialysis (BID). Kidney Blood Press Res. 2018; 43(3): 882–92. DOI: 10.1159/000490336</mixed-citation><mixed-citation xml:lang="en">Shamir A.R., Karembelkar A., Yabes J. et al. Association of intradialytic hypertension with left ventricular mass in hypertensive hemodialysis patients enrolled in the Blood Pressure in Dialysis (BID). Kidney Blood Press Res. 2018; 43(3): 882–92. DOI: 10.1159/000490336</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Park J., Rhee C.M., Sim J.J. et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int. 2013; 84(4): 795–802. DOI: 10.1038/ki.2013.237</mixed-citation><mixed-citation xml:lang="en">Park J., Rhee C.M., Sim J.J. et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int. 2013; 84(4): 795–802. DOI: 10.1038/ki.2013.237</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Khan A., Khan A.H., Adnan A.S. et al. Management of patient care in hemodialysis while focusing on cardiovascular disease events and the atypical role of hyperand/or hypotension: a systematic review. Biomed. Res. Int. 2016; 2016: 9710965. DOI: 10.1155/2016/9710965</mixed-citation><mixed-citation xml:lang="en">Khan A., Khan A.H., Adnan A.S. et al. Management of patient care in hemodialysis while focusing on cardiovascular disease events and the atypical role of hyperand/or hypotension: a systematic review. Biomed. Res. Int. 2016; 2016: 9710965. DOI: 10.1155/2016/9710965</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Yang C.Y., Yang W.C., Lin Y.P. Postdialysis blood pressure rise predicts long-term outcomes in chronic hemodialysis patients: a four-year prospective observational cohort study. BMC Nephrol. 2012; 13: 12. DOI: 10.1186/1471-2369-13-12</mixed-citation><mixed-citation xml:lang="en">Yang C.Y., Yang W.C., Lin Y.P. Postdialysis blood pressure rise predicts long-term outcomes in chronic hemodialysis patients: a four-year prospective observational cohort study. BMC Nephrol. 2012; 13: 12. DOI: 10.1186/1471-2369-13-12</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Assimon M.M., Wang L., Flythe J.E. Intradialytic hypertension frequency and short-term clinical outcomes among individuals receiving maintenance hemodialysis. Am. J. Hypertens. 2018; 31(3): 329–39. DOI: 10.1093/ajh/hpx186</mixed-citation><mixed-citation xml:lang="en">Assimon M.M., Wang L., Flythe J.E. Intradialytic hypertension frequency and short-term clinical outcomes among individuals receiving maintenance hemodialysis. Am. J. Hypertens. 2018; 31(3): 329–39. DOI: 10.1093/ajh/hpx186</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bailie G.R., Mason N.A. 2013 Dialysis of drugs. Saline (USA): Renal Pharmacy Consultants LLC; 2013.</mixed-citation><mixed-citation xml:lang="en">Bailie G.R., Mason N.A. 2013 Dialysis of drugs. Saline (USA): Renal Pharmacy Consultants LLC; 2013.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Georgianos P.I., Sarafidis P.A., Zoccali C. Intradialytic hypertension in end-stage renal disease patients: clinical epidemiology, pathogenesis, and treatment. Hypertension. 2015; 66(3): 456–63. DOI: 10.1161/HYPERTENSIONAHA.115.05858</mixed-citation><mixed-citation xml:lang="en">Georgianos P.I., Sarafidis P.A., Zoccali C. Intradialytic hypertension in end-stage renal disease patients: clinical epidemiology, pathogenesis, and treatment. Hypertension. 2015; 66(3): 456–63. DOI: 10.1161/HYPERTENSIONAHA.115.05858</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Nongnuch A., Campbell N., Stern E. et al. Increased postdialysis systolic blood pressure is associated with extracellular overhydration in hemodialysis outpatients. Kidney Int. 2015; 87(2): 452–7. DOI: 10.1038/ki.2014.276</mixed-citation><mixed-citation xml:lang="en">Nongnuch A., Campbell N., Stern E. et al. Increased postdialysis systolic blood pressure is associated with extracellular overhydration in hemodialysis outpatients. Kidney Int. 2015; 87(2): 452–7. DOI: 10.1038/ki.2014.276</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Van Buren P.N. Pathophysiology and implications of intradialytic hypertension. Curr. Opin. Nephrol. Hypertens. 2017; 26(4): 303–10. DOI: 10.1097/MNH.0000000000000334</mixed-citation><mixed-citation xml:lang="en">Van Buren P.N. Pathophysiology and implications of intradialytic hypertension. Curr. Opin. Nephrol. Hypertens. 2017; 26(4): 303–10. DOI: 10.1097/MNH.0000000000000334</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Inrig J.K., Van Buren P.N., Kim C. et al. Intradialytic hypertension and its association with endothelial cell dysfunction. Clin. J. Am. Soc. Nephrol. 2011; 6(8): 2016–24. DOI: 10.2215/CJN.11351210</mixed-citation><mixed-citation xml:lang="en">Inrig J.K., Van Buren P.N., Kim C. et al. Intradialytic hypertension and its association with endothelial cell dysfunction. Clin. J. Am. Soc. Nephrol. 2011; 6(8): 2016–24. DOI: 10.2215/CJN.11351210</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rubinger D., Backenroth R., Sapoznikov D. Sympathetic activation and baroreflex function during intradialytic hypertensive episodes. PLoS One. 2012; 7(5): e36943. DOI: 10.1371/journal. pone.0036943</mixed-citation><mixed-citation xml:lang="en">Rubinger D., Backenroth R., Sapoznikov D. Sympathetic activation and baroreflex function during intradialytic hypertensive episodes. PLoS One. 2012; 7(5): e36943. DOI: 10.1371/journal. pone.0036943</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Teng J., Tian J., Lv W.L. et al. Inappropriately elevated endothelin-1 plays a role in the pathogenesis of intradialytic hypertension. Hemodial. Int. 2015; 19(2): 279–86. DOI: 10.1111/hdi.12238</mixed-citation><mixed-citation xml:lang="en">Teng J., Tian J., Lv W.L. et al. Inappropriately elevated endothelin-1 plays a role in the pathogenesis of intradialytic hypertension. Hemodial. Int. 2015; 19(2): 279–86. DOI: 10.1111/hdi.12238</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
